Annual General Meeting results

RNS Number : 3733E
The MedicX Fund Limited
08 February 2018
 

 

 

Press Release

For immediate release                                                                                    

8 February 2018

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

 

Annual General Meeting results

 

The Board of MedicX Fund Limited is pleased to announce that at the Annual General Meeting of its Shareholders held earlier today, each of the resolutions was duly proposed and passed by the appropriate majority. The details of the number of votes recorded in respect of each resolution was as follows:

 

The following resolutions were passed as ordinary resolutions:

Resolution

In favour

% In favour

Against

% Against

Votes withheld

1.  To reappoint KPMG LLP as auditors

182,400,582

99.99

12,034

0.01

15,750

2.  To authorise the Directors to determine the auditors' remuneration

182,428,366

100.00

-

-

-

3.  To approve the Annual Report and Financial Statements

182,384,573

99.98

43,792

0.02

-

4.  To approve the dividend policy

182,418,366

99.99

10,000

0.01

-

5.  To approve the directors' remuneration report

181,246,005

99.96

66,429

0.04

562

6.  To re-appoint John Hearle as director

182,316,619

99.95

93,963

0.05

17,784

7.  To re-appoint Stephen Le Page as director

181,181,854

99.94

113,358

0.06

17,784

8.  To appoint Helen Mahy as director

182,318,653

99.95

93,963

0.05

15,750

9.  To appoint Laure Duhot as director

181,195,888

99.94

101,358

0.06

15,750

 

The following resolutions were passed as special resolutions:

Resolution

In favour

% In favour

Against

% Against

Votes withheld

10.  Renewal of directors' authority to issue shares

182,393,497

99.99

22,869

0.01

12,000

11.  To authorise the Company to make market acquisitions of its ordinary shares (not exceeding 14.99 per cent. of its issued share capital, excluding treasury shares).

182,357,187

99.96

71,179

0.04

-

12.  (That subject to resolution 10) to authorise the directors to issue ordinary shares in the Company on a non pre-emptive basis

182,402,655

99.99

9,000

0.01

16,711

 

Notes:

·          A vote "withheld" is not a vote in law and is not calculated in the proportion of the votes "in favour" or "against" the resolution.

·          The total number of voting rights at the proxy deadline was 428,833,331.

 

For further information please contact:

 

Octopus Healthcare Adviser Ltd                                                    +44 (0) 345 0404 5555

 

Octopus Healthcare Group                                                           +44 (0) 20 3142 4820

Mike Adams, Chief Executive Officer

 

Canaccord Genuity

Andrew Zychowski/Helen Goldsmith                                             +44 (0) 20 7523 8000

 

Buchanan                                                                                  +44 (0) 20 7466 5000

Charles Ryland/Vicky Hayns

 

 

Information on MedicX Fund Limited

 

MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 153 properties.

 

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.2 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 100,000 customers

 

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGEAKAPELSPEFF
UK 100

Latest directors dealings